| Mascolini M, Boucher CA, Mellors JW, et al.
Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. [Journal Article]
Antivir Ther 2009; 14(7):1015-37.
Abstract | Full Citation | | Eholié SP, Ouiminga M, Ehui E, et al.
Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease. [Journal Article]
Antivir Ther 2009; 14(7):1011-4.
Abstract | Full Citation | | Vidya M, Saravanan S, Uma S, et al.
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India. [Journal Article]
Antivir Ther 2009; 14(7):1005-9.
Abstract | Full Citation | | van der Lugt J, Lange J, Avihingsanon A, et al.
Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals. [Journal Article]
Antivir Ther 2009; 14(7):1001-4.
Abstract | Full Citation | | Audelin AM, Lohse N, Obel N, et al.
The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005. [Journal Article]
Antivir Ther 2009; 14(7):995-1000.
Abstract | Full Citation | | Choe WH, Hong SP, Kim BK, et al.
Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir. [Journal Article]
Antivir Ther 2009; 14(7):985-93.
Abstract | Full Citation | | Huang KH, Goedhals D, Fryer H, et al.
Prevalence of HIV type-1 drug-associated mutations in pre-therapy patients in the Free State, South Africa. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(7):975-984.
Abstract | Full Citation | | Janneh O, Anwar T, Jungbauer C, et al.
P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir. [Journal Article]
Antivir Ther 2009; 14(7):965-74.
Abstract | Full Citation | | Tschochner M, Chopra A, Maiden TM, et al.
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance. [Journal Article]
Antivir Ther 2009; 14(7):953-64.
Abstract | Full Citation | | Donne AJ, Hampson L, He XT, et al.
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(7):939-952.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
